QCL is a CDMO privately owned and led by Dr. Yousry Sayed since 1998. We have grown to encompass product development and clinical manufacturing. QCL excels in pre-formulation, formulation development, and getting early phase clinical trial materials to clinics on aggressive timelines. We provide analytical development and validation, stability studies, and testing of APIs, finished products, and raw materials. New construction will double our footprint to 180,000 ft2 by Q1 2022 expanding services into late phase clinical and commercial GMP manufacturing including state of the art sterile fill-finish for both small and large molecules.
Adds staff and critical instrumentation to the E&L group